Target intelligence / Profile preview

RNA, U6 small nuclear 281, pseudogene (RNU6-281P)

Target
RNU6-281P
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA-related pseudogene
01

Overview

RNA, U6 small nuclear 281, pseudogene (RNU6-281P) is annotated as a pseudogene of U6 small nuclear RNA (snRNA) in Homo sapiens[1][3][5]. The U6 snRNA genes are components of the spliceosome complex and are essential for pre-mRNA splicing, but pseudogenes like RNU6-281P are typically non-functional genomic copies that do not encode functional U6 snRNAs[2][3]. Most snRNA pseudogenes, including those of the U6 family, are considered non-expressed and not actively involved in known spliceosomal or regulatory processes[2][4]. There is currently no evidence that RNU6-281P is functionally expressed or has disease associations. While some pseudogenes can act as regulatory RNAs or competitive endogenous RNAs (ceRNAs), this has not been directly demonstrated for RNU6-281P[4]. Thus, it is generally considered a non-functional genomic element with no established role in therapy, diagnosis, or biology. Assessment: RNU6-281P does not encode a receptor, enzyme, or other protein[1][3][5]. The name matches database records, and while it is not a functional target, it is correctly annotated as a pseudogene, and there is no evidence of misspelling or record error[1][3][5]. No literature currently attributes a biological or pathological function specifically to this pseudogene.

Other names
RNU6-281P
02

Biological functions

No known canonical biological activity
03

Disease associations

No known disease association

Beyond the preview

Go deeper on RNA, U6 small nuclear 281, pseudogene (RNU6-281P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 281, pseudogene (RNU6-281P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call